Thomas F. Durand-Réville

Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases

David E. Ehmann, Haris Jahić, Philip L. Ross et al. · Journal of Biological Chemistry · 2013 · 355 citations · Full text

Life Sciences, Microbiology, Pharmacokinetics +16

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 271 citations

Life Sciences, Infectious Diseases, Microbiology +16

Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases

Sushmita D. Lahiri, Stefano Mangani, Thomas F. Durand-Réville et al. · Antimicrobial Agents and Chemotherapy · 2013 · 221 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Rational design of a new antibiotic class for drug-resistant infections

Thomas F. Durand-Réville, Alita A. Miller, John P. O’Donnell et al. · Nature · 2021 · 140 citations

Life Sciences, Infectious Diseases, Medicinal Chemistry +16

Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48

Sushmita D. Lahiri, Stefano Mangani, Haris Jahić et al. · ACS Chemical Biology · 2014 · 100 citations

Life Sciences, Microbiology, Pharmacology +17